Update: SAHPRA Approves Lenacapavir For HIV Prevention

SAHPRA Approves Lenacapavir For HIV Prevention

SAHPRA's approval for lenacapavir is crucial for the country to begin drug rollout, expected by April 2026.

In other news, communities face various challenges, including inadequate access to basic services.

Drastic measures had to be taken to avoid the total collapse of the community-led monitoring programme.

No direct quote available.

Author summary: SAHPRA approves lenacapavir for HIV prevention rollout.

more

Health-e News Health-e News — 2025-10-27

More News